This study evaluates the feasibility of hypofractionated radiotherapy (RT) in the palliative treatment of recurrent diffuse intrinsic pontine glioma (DIPG). Participants will receive 15 Gy in 3 fractions as opposed to the standard 20 Gy in 10 fractions.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
5
Radiotherapy Treatment, totaling 15 Gy, will be given in 3 fractions over 2 weeks.
University of Cincinnati
Cincinnati, Ohio, United States
Post Radiation Toxicity
RTOG common toxicity criteria grade 0-5
Time frame: Through Study Completion, an average of 1 year
Change in Quality of Life score
Patient reported quality of life via Pediatric Quality of Life Inventory Version 4.0
Time frame: Pre-RT, 2 weeks, 1 month, 3 months and every 3 months there-after post RT
Radiographic Response
Physician documented change of tumor from pre-RT MRI as compared to 1 month post-RT MRI
Time frame: 1 month
Progression Free Survival
Time to clinical, symptomatic or radiographic evidence of disease progression
Time frame: Through Study Completion, an average of 1 year
Overall Survival
Time to patient death
Time frame: Through Study Completion, an average of 1 year
Steroid Requirement
Use of steroids post-RT
Time frame: Through Study Completion, an average of 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.